Librela
Country: European Union
Language: Lithuanian
Source: EMA (European Medicines Agency)
Patient Information leaflet
(PIL)
31-05-2024
Summary of Product characteristics
(SPC)
31-05-2024
Public Assessment Report
(PAR)
31-05-2024
Active ingredient:
bedinvetmab
Available from:
Zoetis Belgium
ATC code:
QN02B
INN (International Name):
bedinvetmab
Therapeutic group:
Šunys
Therapeutic area:
Analgetikai
Therapeutic indications:
For the alleviation of pain associated with osteoarthritis in dogs.
Product summary:
Revision: 1
Authorization status:
Įgaliotas
Authorization date:
2020-11-10
Patient Information leaflet
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.
Read the complete document
Summary of Product characteristics
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.
Read the complete document
